Cardlytics Stock Statistic Functions Beta
| CDLX Stock | USD 0.69 0.02 2.51% |
| Symbol |
This analysis covers thirty-seven data points across the selected time horizon. The Beta measures systematic risk based on how returns on Cardlytics correlated with the market. If Beta is less than 0 Cardlytics generally moves in the opposite direction as compared to the market. If Cardlytics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cardlytics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cardlytics is generally in the same direction as the market. If Beta > 1 Cardlytics moves generally in the same direction as, but more than the movement of the benchmark.
Cardlytics Technical Analysis Modules
Most technical analysis of Cardlytics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cardlytics from various momentum indicators to cycle indicators. When you analyze Cardlytics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia. Cardlytics operates under Advertising Agencies classification in the United States and is traded on NASDAQ Exchange. It employs 710 people. This overview emphasizes how Cardlytics compares to peers on valuation quality and operating consistency. Current metrics include P/B of 1.58, profit margin of -44.36%. Cardlytics has a market cap of 37.15 M, ROE of -3.26%.
Methodology
Unless otherwise specified, financial data for Cardlytics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Cardlytics (USA Stocks:CDLX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR. Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Cardlytics may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardSome investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cardlytics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cardlytics' short interest history, or implied volatility extrapolated from Cardlytics options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Driverless Cars Invested few shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Hedge Favorites Invested over 40 shares | |
 | FinTech Invested over 20 shares | |
 | Advertising Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Momentum Invested few shares | |
 | Investor Favorites Invested over 20 shares | |
 | Social Domain Invested few shares | |
More Resources for Cardlytics Stock Analysis
A structured review of Cardlytics often starts with core financial statements and trend context. Ratio analysis helps investors evaluate Cardlytics Stock operating efficiency and financial trajectory. Highlighted below are reports that provide context for Cardlytics Stock:Cardlytics has a market cap of 37.15 M, operating margin of -9.87%, ROE of -3.26%. Use Trending Equities to explore allocation context. This includes a position in Cardlytics within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. Our How to Invest in Cardlytics guide provides practical guidance on trading Cardlytics Stock.Cardlytics currently shows ROE of -3.26%, market cap of 37.15 Million. This analysis of Cardlytics works best as a complementary layer when evaluating how the security fits in a broader portfolio. The supplemental views below help investors decide how Cardlytics complements or overlaps with existing portfolio holdings. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Quarterly Earnings Growth -0.57 | Earnings Share -1.95 | Revenue Per Share | Quarterly Revenue Growth -0.24 | Return On Assets |
Investors evaluate Cardlytics using market value and book value, each describing different facets of the business. Cardlytics' market capitalization is 37.15 M. At P/B 1.58, Cardlytics trades moderately above book value. Enterprise value stands at 203.87 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
The concept of value for Cardlytics differs from its quoted price, since each reflects a different lens. For Cardlytics, key inputs include a P/B ratio of 1.58, a profit margin of -44.36%, ROE of -3.26%, and revenue of 233.27 M. Where Cardlytics trades at any moment depends on the balance of buying and selling pressure.